MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2025.115883

Медицинская библиотека · International immunopharmacology · 2025

Baicalin inhibits the Akt/mTOR/ULK1 signaling pathway to activate autophagy and ameliorate pulmonary fibrosis.

Hu Xu-Liang, Liang Qing, Jie Zhi-Jun, Chen Wan-Sheng, Deng Jiu-Ling, Sun Guang-Chun

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disorder pathologically characterized by epithelial-mesenchymal transition (EMT) and aberrant extracellular matrix (ECM) accumulation. Autophagy dysfunction has recently been implicated in the pathogenesis of IPF. Baicalin (Bai), a natural flavonoid glycoside, has demonstrated anti-fibrotic potential, yet its role in modulating autophagy in IPF remains unclear.

OBJECTIVE

The study analyzed the protective effect of Baicalin on IPF, focusing on its ability to modulate autophagy and inhibit EMT.

METHODS

A classic murine model of IPF was induced by a single intratracheal injection of BLM and treated with Baicalin (50 mg/kg, 100 mg/kg, i.g.), pirfenidone (150 mg/kg, i.g.), or hydroxychloroquine (HCQ, 60 mg/kg, i.p.). In vitro, MLE-12 cells stimulated by TGF-β1 were subjected to Baicalin treatment. (10-40 μM). Fibrosis, autophagy activity, and EMT markers were assessed using histopathology, Micro-CT, Western blot, immunofluorescence, and transmission electron microscopy. The autophagy inhibitor 3-MA, activator rapamycin, and Akt agonist SC-79 were employed for mechanistic validation.

RESULTS

Baicalin treatment significantly ameliorated pulmonary fibrosis, inhibited EMT, reduced lung index, collagen deposition, and inflammation, as well as enhanced autophagy in BLM-challenged mice. In TGF-β1-stimulated MLE-12 cells, Baicalin reversed autophagy impairment and EMT progression. Mechanistically, autophagy inhibitors (3-MA, HCQ) counteracted Baicalin's anti-fibrotic effects. Baicalin suppressed Akt/mTOR/ULK1 signaling activation by decreasing p-Akt, p-mTOR, and p-ULK1 levels. The Akt agonist SC-79 abrogated Baicalin-induced autophagy restoration and EMT inhibition.

CONCLUSION

Baicalin alleviated pulmonary fibrosis by activating autophagy and inhibiting EMT via the Akt/mTOR/ULK1 pathway. Our research offers new pharmacological insights into IPF treatment that targets autophagy.

Для цитирования: Hu Xu-Liang, Liang Qing, Jie Zhi-Jun, Chen Wan-Sheng, Deng Jiu-Ling, Sun Guang-Chun. Baicalin inhibits the Akt/mTOR/ULK1 signaling pathway to activate autophagy and ameliorate pulmonary fibrosis.. International immunopharmacology. 2025. DOI: 10.1016/j.intimp.2025.115883.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.